(subsidiary of Phalanx Biotech Group)
PhalanxBio Inc, is a subsidiary of the parent company, Phalanx Biotech Group (Taiwan) which was established in 2002, as an offshoot of the prestigious Industrial Technology Research Institute of Taiwan (ITRI). In 2013, PhalanxBio Inc moved to San Diego, CA to be part of the thriving local biotech community and to provide comprehensive genomic services and bioinformatics to the life science research community.
Phalanx Biotech Group is the original manufacturer for the OneArray® brand of microarrays and has developed a stellar reputation (with almost 400 publications) in the research use of its own microarray line. The Phalanx service lab is known globally for its delivery of high quality data. Phalanx is able to provide custom printing solutions and probe design to global customers.
On the clinical front, Phalanx Biotech Group has pioneered its own CytoOneArray microarray chip, for detecting developmental delays. This product and complementary service is only available in the U.S. for research purposes and not yet approved for clinical diagnostics. However, its clinical use is being implemented internationally.
Phalanx Biotech’s capabilities include microarray service, miRNA service, qRT-PCR, custom printing, Next Generation Sequencing (NGS) and an entire suite of complementary bioinformatics analyses.
Here are some of our key team members:
CEO of Phalanx Biotech Group
Sybil joined as Chairman of the Board of Phalanx Biotech Group in 2014. Her successful track record includes having been CEO for Huga Optotech, and growing the company’s market capitalization by 20x during her tenure. Even during the financial crisis of 2008 and 2009, Optatech was rated as one of the “Technology Fast 50” by Deloitte. Prior to that, Sybil was Chief Investment Officer at Yageo, as well as a CFA charter-holder doing industry research, security valuation and portfolio management at Baring Security IIT and Prergnie Securities. She was in charge of Taiwan’s first GDR and Eurobond offerings, working closely with Far Eastern New Century’s CEO and CFO.
CEO of PhalanxBio Inc, PRESIDENT of Phalanx Biotech Group
Richard joined Phalanx in 2015 and is the President of Phalanx Biotech Group, lending his extensive business expertise to direct the Sales and Marketing. Richard was formerly the President of Fuji Xerox Document Management Solution (DMS), Taiwan. He was instrumental in helping the company become the first Document Management Service provider to offer an inbound and outbound total solution to the financial industry. An active business leader, Richard is also a founding member and a Director of the Board of the Australia and New Zealand Commercial Chambers, in Taiwan.
Mireille Davis, OMCP
Business Development Manager, PhalanxBio Inc.
Mireille joined PhalanxBio Inc in 2013. Mireille provides leadership to the U.S. and International Sales teams and oversees the staff and the general operation of the U.S. branch. Mireille has credentials as an Online Marketing Certified Professional and has 15+ years of experience across digital marketing and business development. She is a successful entrepreneur and businesswoman, having founded and run Extreme Soundproofing (an acoustical E-Commerce company). Previously, Mireille was a Procedure Writer/Supervisor for Southern California Edison at San Onofre Nuclear Generation Station. She is a CSULB alumni.
Lorraine Provencio, Ph.D
Sequencing Sales/Support Specialist
Lorraine is the Sequencing Sales/Support Specialist at PhalanxBio Inc. in San Diego, California. Lorraine received her PhD in Molecular Biology from the University of Southern California in Los Angeles. Her doctoral research involved the use of next generation sequencing to elucidate candidate loci underlying phenotypes of interest. As a scientist, she has experience addressing many questions that may come up when formulating and carrying out experimental protocols. If Lorraine is not reading, writing or talking science she is probably outside. Her hobbies include running, hiking and exploring the San Diego terrain.